Segui
Karin Purshouse
Titolo
Citata da
Citata da
Anno
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ...
The Lancet 395 (10241), 1919-1926, 2020
11942020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ...
The Lancet Oncology 21 (10), 1309-1316, 2020
6092020
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
PL Sulkowski, CD Corso, ND Robinson, SE Scanlon, KR Purshouse, ...
Science translational medicine 9 (375), eaal2463, 2017
5032017
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
LL da Motta, I Ledaki, K Purshouse, S Haider, MA De Bastiani, D Baban, ...
Oncogene 36 (1), 122-132, 2017
1522017
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
I Anil, R Arnold, S Benkwitz-Beford, S Branford, N Campton, JB Cazier, ...
The Lancet Oncology 21 (5), 622-624, 2020
692020
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
AJX Lee, K Purshouse
British Journal of Cancer 124 (11), 1777-1784, 2021
592021
Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19
C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ...
JAMA network open 5 (2), e220130-e220130, 2022
482022
Challenges to DNA replication in hypoxic conditions
N Ng, K Purshouse, IP Foskolou, MM Olcina, EM Hammond
The FEBS journal 285 (9), 1563-1571, 2018
472018
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti …
S Booth, HM Curley, C Varnai, R Arnold, LYW Lee, NA Campton, G Cook, ...
British Journal of Haematology 196 (4), 892-901, 2022
312022
Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanoma
R Sinha, K Lecamwasam, K Purshouse, J Reed, MR Middleton, ...
British Journal of Dermatology 170 (4), 997-999, 2014
302014
Value of supraregional multidisciplinary review for the contemporary management of testicular tumors
K Purshouse, RA Watson, DN Church, C Richardson, G Crane, Z Traill, ...
Clinical Genitourinary Cancer 15 (1), 152-156, 2017
282017
Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer
C Palmieri, MP Caley, K Purshouse, AV Fonseca, M Rodriguez-Teja, ...
British journal of cancer 108 (1), 163-169, 2013
242013
Distinguishing between direct and indirect consequences of covid-19
JD Figueroa, PM Brennan, E Theodoratou, MTC Poon, K Purshouse, ...
Bmj 369, 2020
202020
UK Coronavirus Monitoring Project Team: COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study
LY Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ...
Lancet 395 (10/241), 1919-1926, 2020
192020
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
OJ Pickles, LYW Lee, T Starkey, L Freeman-Mills, A Olsson-Brown, ...
British journal of cancer 123 (5), 691-693, 2020
172020
UK Coronavirus Cancer Monitoring Project Team COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a …
LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ...
Lancet Oncol 21 (10), 1309-1316, 2020
152020
Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells
K Purshouse, ET Friman, S Boyle, PS Dewari, V Grant, A Hamdan, ...
Elife 11, e80207, 2022
132022
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer
K Purshouse, A Schuh, BP Fairfax, S Knight, P Antoniou, H Dreau, ...
Molecular Case Studies 3 (3), a001362, 2017
132017
Trends in excess cancer and cardiovascular deaths in Scotland during the COVID-19 pandemic 30 December–20 April suggest underestimation of COVID-19 related deaths
JD Figueroa, P Brennan, E Theodoratou, M Poon, K Purshouse, F Din, ...
medRxiv, 2020.05. 02.20086231, 2020
102020
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
VK Woodcock, K Purshouse, C Butcher, C Haddon, G Verrall, L Elhussein, ...
Journal of Clinical Oncology 37 (7_suppl), 406-406, 2019
102019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20